ArticleMethods in molecular biology (Clifton, N.J.)2025
Visualization of Respiratory Syncytial Virus RNA Synthesis Sites by Ethynyl Uridine Labeling.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Modified cell-permeable nucleosides such as 5-bromouridine 5'-triphosphate (BrUTP) or 5-ethynyluridine (5-EU), together with the powerful click chemistry, have been widely used to specifically label newly synthetized RNA in cells and tissues in a simple two-step approach. The use of cellular transcription inhibitors has established metabolic RNA labeling as an optimal approach for the precise visualization of viral RNA transcripts and the microscopic analysis of their distribution in infected cells. The labeling of nascent viral RNA of respiratory syncytial virus (RSV) and other Mononegavirales (MNV) (e.g., rabies virus (RABV), Ebola virus (EBOV), or human metapneumovirus (HMPV)) demonstrated the presence of newly synthesized viral RNAs in virally induced cytoplasmic inclusions called inclusion bodies (IBs). This was the crucial result to confirm that viral RNA synthesis occurs in these IBs, which could thus be renamed viral factories. Here, we describe a method for the unbiased detection of newly synthetized viral RNA in RSV-infected cells via metabolic labeling with 5-EU and subsequent detection using highly specific alkyne-azide "click" chemistry.
Indexed as
Identifiers
40879903What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.